Bisphosphonates, osteonecrosis of the jaw, and dental treatment recommendations
Affiliations
- PMID: 18595621
Item in Clipboard
Bisphosphonates, osteonecrosis of the jaw, and dental treatment recommendations
J Okla Dent Assoc.
2008 Apr-May.
Abstract
Millions of patients in the United States take bisphosphonates for management of malignant bone metastases, osteoporosis, osteitis deformans (Paget's disease), and osteogenesis imperfecta. Since 2003, over 200 cases of osteonecrosis of the jaws have been described, mostly in patients with multiple myeloma or breast cancer patients, and to a lesser extent in patients on oral medications.
Similar articles
-
Bisphosphonates and osteonecrosis of the jaws: science and rationale.Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Aug;104(2):186-93. doi: 10.1016/j.tripleo.2006.12.004. Epub 2007 Apr 20. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007. PMID: 17448709 Review.
-
[Bisphosphonate-associated osteonecrosis of the jaws 1].Ned Tijdschr Tandheelkd. 2007 Oct;114(10):423-7. Ned Tijdschr Tandheelkd. 2007. PMID: 17972610 Dutch.
-
Osteonecrosis and bisphosphonates in oral and maxillofacial surgery.Oral Maxillofac Surg Clin North Am. 2007 May;19(2):199-206, vi. doi: 10.1016/j.coms.2007.01.005. Oral Maxillofac Surg Clin North Am. 2007. PMID: 18088878 Review.
-
Complication related to bisphosphonate therapy: osteonecrosis of the jaw.J Infus Nurs. 2009 Nov-Dec;32(6):330-5. doi: 10.1097/NAN.0b013e3181bd5373. J Infus Nurs. 2009. PMID: 19918142
-
A physician discusses the dental impact of oral bisphosphonates.J Indiana Dent Assoc. 2006-2007 Winter;85(4):4-5. J Indiana Dent Assoc. 2006. PMID: 17489111 No abstract available.
Cited by
-
Malocclusion traits and oral health-related quality of life in children with osteogenesis imperfecta: A cross-sectional study.J Am Dent Assoc. 2020 Jul;151(7):480-490.e2. doi: 10.1016/j.adaj.2020.03.040. J Am Dent Assoc. 2020. PMID: 32593350 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical